Skip to main content
Caplight Logo









Shanghai Refreshgene Technology Co., Ltd.

Shanghai Refreshgene Technology Co., Ltd.

Private
ShanghaiHealthcare & Life Scienceshttps://reforgene.com

Last Round

Series B

Dec 30, 2024

Total Funding Raised

$15.14M

Company Overview

Shanghai Refreshgene Technology Co., Ltd. is a biotechnology company that develops gene therapy drugs for the treatment of chronic and rare diseases, including ophthalmology, otology, cardiovascular, and tumor-related conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

gene therapyadeno-associated virusAAVviral vectorbiotechclinical-stage biotechnon-viral vectorretinal disease therapydual AAV vectorgenetic medicineCDMOcontract manufacturingrare disease treatmentgene delivery platformgenomics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Shanghai Refreshgene Technology Co., Ltd. Comparables

Compare Shanghai Refreshgene Technology Co., Ltd. with similar companies based on industry and business-model similarity.

Shanghai Refreshgene Technology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Exegenesis Bio
86%
Frontera Therapeutics
85%
Neurophth
85%

Shanghai Refreshgene Technology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BDec 30, 2024
Early FundingApr 28, 2023
Series A ExtensionSep 16, 2021
Series ANov 2, 2020
AngelJan 19, 2020

Key People

Founding team and executive leadership

Junbin Liang

Founder and CEO

Founding Team

Jason Wang

Chief Financial Officer

Executive Team

Shanghai Refreshgene Technology Co., Ltd. Investors

Notable investors and investment history

Shanghai Refreshgene Technology Co., Ltd. investors
InvestorRounds
BioTrack CapitalSeries A Extension, Early Funding
Legend StarSeries A, Angel
Guangzhou Industrial Investment Holding GroupSeries B
YuanBio Venture CapitalSeries A Extension
Guangzhou Science and Technology Financial Innovation Investment HoldingSeries B
Sinovation VenturesSeries A Extension
Legend HoldingsAngel

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 30, 2024

    Led by Guangzhou Industrial Investment Holding Group.

  • Apr 28, 2023

    Led by Guangzhou Yuexiu Industrial Investment Fund Management.

Shanghai Refreshgene Technology Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Shanghai Refreshgene Technology Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Shanghai Refreshgene Technology Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Employee Range8
Year Founded2020
Last FundingDec 30, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?